Jordan F. Baye

Tadalafil: A Phosphodiesterase‐5 Inhibitor for Benign Prostatic Hyperplasia

S. Vouri, J. Baye, M. Cantrell, 2013, Pharmacotherapy.

Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety.

N. Petry, J. Baye, Shauna L Jacobson, 2020, Pharmacogenomics.

CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls

R. Wilke, Moataz Ellithi, Jordan F. Baye, 2020, Pharmacogenomics.

Development and early evaluation of clinical decision support for long QT syndrome population screening

N. Petry, Catherine Hajek, J. Baye, 2022, Journal of Translational Genetics and Genomics.

SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care

D. Voora, R. Wilke, Eric A. Larson, 2022, Clinical pharmacology and therapeutics.

Rationale and design for a pragmatic randomized trial to assess gene‐based prescribing for SSRIs in the treatment of depression

S. V. Van Driest, J. Murrough, Benjamin Q Duong, 2024, Clinical and translational science.

Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators

S. Volpi, D. Voora, P. Dexter, 2022, Clinical and translational science.